At the heart of this discovery lies nanoporous gold, an innovative metamaterial engineered with a sponge-like architecture that diverges dramatically from traditional solid gold. This three-dimensional nanoscale porosity isn’t merely a curiosity of structure — it fundamentally reshapes how gold absorbs and amplifies electromagnetic radiation. When subjected to ultrashort laser pulses, nanoporous gold exhibits a striking capacity to capture and retain light energy over a broader spectral range, far surpassing the abilities of ordinary gold films.

Central to this phenomenon is the way electronic excitations emerge within the porous network. As laser pulses excite the gold electrons, the material’s architecture concentrates and confines the energy, pushing the electronic temperature to extraordinary heights. Measurements estimate that the electrons in nanoporous gold can reach temperatures near 3200 Kelvin — roughly equivalent to 2900 degrees Celsius — under laser exposure. This intense excitation is more than triple the electron temperature observed in a standard, non-structured gold film under identical conditions, where electron temperatures hover around 800 Kelvin.

The prolonged cooling time of these “hot” electrons within the nanoporous matrix is equally significant. Instead of quickly dissipating energy to the surrounding lattice — as occurs in bulk gold — the electrons linger in their excited state. This extended relaxation period opens avenues for light-induced electronic transitions that are conventionally inaccessible in solid gold. Consequently, nanoporous gold not only harnesses light more efficiently but also sustains energetic states that can drive advanced photophysical and photochemical processes.

What makes these findings particularly compelling is the confirmation that the enhancements stem solely from the physical morphology of the gold, rather than any chemical or compositional alterations. Through sophisticated analytical techniques such as advanced electron microscopy and X-ray photoelectron spectroscopy conducted at Umeå University, researchers rigorously demonstrated that the intrinsic electronic structure of gold remains unaltered. It is the nanoscale architecture — the shape and distribution of voids and ligaments — that is the true orchestrator of these extraordinary optical and electronic effects.

This structural approach heralds a paradigm shift: material properties can be precisely engineered by tuning the architecture at the nanoscale, an idea resonating across materials science. By adjusting the “filling factor” — the ratio of gold to air within the porous framework — the electronic response of nanoporous gold can be systematically modified. This tunability introduces an entirely new parameter for designing materials with targeted functionalities, transcending the traditional reliance on chemical composition and atomic-scale doping alone.

The implications for practical applications are expansive and profound. In catalysis, for instance, the ability to sustain “hot” electrons and absorb a wider swath of light energy could dramatically enhance reaction kinetics for processes such as hydrogen production or carbon dioxide reduction. These are vital reactions for clean energy technologies and climate mitigation, making the efficient manipulation of electronic states a high priority in sustainable chemistry.

Furthermore, the insights gained from nanoporous gold metamaterials pave the way for improved plasmonic devices, where controlling electron dynamics is paramount. Photonic sensors, optical switches, and nanoscale lasers may all benefit from materials whose optical response can be constantly tuned through morphology. Nanoporous gold’s superior light-harvesting capability under ultrafast optical stimulation also offers exciting prospects in developing next-generation photovoltaic cells and energy conversion systems.

Beyond renewable energy and catalysis, the research hints at revolutionary advances in medicine and quantum technologies. Materials exhibiting prolonged electronic excitation lifetimes could enable novel quantum batteries with enhanced charge retention or drive localized photothermal therapies with greater precision and effectiveness. The convergence of nanofabrication and photophysics embodied by nanoporous gold opens unexplored frontiers in designing smart materials tailored for diverse scientific and technological demands.

The study exemplifies a growing recognition that the interplay between a material’s shape and its quantum electronic behavior is a fertile ground for discoveries. By methodically engineering the nanostructure, researchers transform ordinary metals into extraordinary functional metamaterials, thereby expanding the toolkit available for addressing global challenges in energy, environment, and technology innovation.

Tlek Tapani, the doctoral researcher leading the experiments on light absorption, emphasizes the transformative potential: “Our results illustrate that architecture on the nanoscale is not a trivial design choice—it’s a powerful lever to manipulate how materials behave at fundamental levels.” Senior author Nicolò Maccaferri adds, “This work unravels new physical pathways for controlling electronic transitions harnessed by light, fundamentally shaping how we envision and create materials for future technologies.”

As the field advances, nanoporous gold stands as a striking demonstration that the future of materials science lies not only in chemistry but profoundly in the geometry of matter. From the microcosm of nanoscale pores to the macrocosm of sustainable applications, the marriage of morphology and function is poised to spark a revolution that redefines what is possible in the realm of plasmonics and beyond.

Subject of Research: Not applicable

Article Title: Morphology-modified contributions of electronic transitions to the optical response of plasmonic nanoporous gold metamaterial

News Publication Date: 20-Jan-2026

Web References:
DOI: 10.1038/s41467-026-68506-0

Image Credits: Photo by Mattias Pettersson, Umeå University

Keywords

Nanoporous materials, Metamaterials, Materials engineering, Physical properties, Electronics, Laser physics, Optical properties

PPARγ, a nuclear receptor with established roles in glucose metabolism and insulin sensitivity, has been extensively studied in metabolic disorders but only recently explored in the context of cancer biology. Its function as a transcription factor enables it to orchestrate a diverse array of cellular processes by modulating gene expression linked to lipid metabolism, inflammation, and cellular differentiation. Given this multifaceted influence, the protein represents a critical mechanistic node connecting metabolic regulation with cancer cell proliferation and tumor microenvironment dynamics.

The research team, headed by Professor Lukas Kenner, who serves as a visiting professor at Umeå University’s Department of Molecular Biology, conducted a retrospective clinical analysis combined with laboratory experiments on cell cultures and murine models. They specifically evaluated a cohort of 69 prostate cancer patients diagnosed with type 2 diabetes, under clinical surveillance at the Medical University of Innsbruck from 2014 to 2023. The team correlated treatment with pioglitazone, a thiazolidinedione-class PPARγ agonist, not only with prolonged relapse-free survival but also with metabolic reprogramming effects observed at the cellular level.

Pioglitazone exerts its biological activity by agonistically binding to PPARγ receptors, leading to altered transcriptional activity of target genes. This interaction changes signal transduction cascades involved in metabolic homeostasis and inflammation, which are pathways frequently hijacked by cancer cells to sustain unregulated growth and resist apoptosis. Interestingly, in studied prostate cancer cell lines, pioglitazone was able to suppress proliferative signals while simultaneously inducing metabolic shifts that weakened the energetic and biosynthetic capacity of the malignant cells, thereby hampering their growth potential.

The implications of these findings are profound because they suggest the possibility of repurposing an already-approved anti-diabetic medication as a component of prostate cancer management, particularly for patients with metabolic comorbidities. However, Professor Kenner emphasizes that while these preliminary clinical observations and preclinical data are promising, rigorous prospective clinical trials are essential to confirm efficacy, optimize dosing strategies, and evaluate whether similar benefits may extend to prostate cancer patients without diabetes.

Moreover, the potential dual action of pioglitazone—modulating both tumor metabolism and the inflammatory milieu—could represent a therapeutic paradigm that addresses tumor progression holistically. Chronic inflammation and altered metabolism are increasingly recognized as hallmarks of cancer, and targeting PPARγ may counteract malignant phenotypes by tipping the balance back toward cellular homeostasis and immune surveillance.

Importantly, variations in PPARγ function have been implicated in different cancer types, with evidence suggesting it might play contrasting roles depending on cancer context and cellular environment. In some malignancies, PPARγ activation might promote differentiation and slow growth, whereas in others, it may fuel tumorigenesis. Therefore, dissecting the molecular underpinnings within prostate cancer cells that enable pioglitazone’s anti-proliferative effects remains a critical area for future research.

The multi-institutional study involved collaboration across Austria, the Czech Republic, Germany, the United Kingdom, and Sweden, highlighting the growing trend of international cooperation in tackling complex diseases like cancer through integrative biomedical approaches. This pooling of expertise and resources has enabled a comprehensive investigation spanning epidemiological analysis, molecular biology, and pharmacology.

Clinically, prostate cancer represents one of the most frequently diagnosed malignancies in men worldwide, with treatment options ranging from surgery and radiation to hormone therapy and chemotherapy. Despite advances, recurrence and resistance remain challenging. The novel insight that a metabolic regulator like pioglitazone could contribute to delaying or preventing recurrence offers hope for expanding the therapeutic toolkit and improving long-term patient outcomes.

At the molecular level, the reprogramming of cancer metabolism induced by pioglitazone involves shifting energy production pathways, potentially restricting the availability of key substrates required for rapid cell division. These alterations may induce a metabolic bottleneck, curbing proliferation and sensitizing tumors to other interventions. Additionally, by modulating PPARγ, pioglitazone might attenuate pro-inflammatory signaling pathways that contribute to a tumor-promoting microenvironment.

Given the rising prevalence of type 2 diabetes worldwide, understanding the intersection between metabolic diseases and cancer biology is critical. This study exemplifies how drugs designed for metabolic disorders can be repurposed for oncological benefit, opening a new frontier in translational medicine focused on metabolism-centric therapies.

The authors note that while pioglitazone has known side effects primarily related to fluid retention and cardiovascular risk, the therapeutic balance may be favorable in prostate cancer patients with concurrent diabetes, where the drug’s benefits could outweigh its risks. Careful patient stratification and monitoring will be paramount in any future clinical trial design exploring this promising avenue.

In conclusion, this pioneering research suggests that the anti-diabetic drug pioglitazone offers a compelling candidate for prostate cancer treatment through its ability to inhibit tumor cell proliferation and induce profound metabolic reprogramming mediated by activation of PPARγ. This breakthrough not only highlights the intricate interplay between metabolism and cancer but also underscores the potential for existing pharmaceuticals to be harnessed in novel therapeutic contexts, heralding a new era of innovative, metabolism-targeted oncology.

—

Subject of Research: The role of the anti-diabetic PPARγ agonist pioglitazone in inhibiting prostate cancer cell proliferation and inducing metabolic reprogramming.

Article Title: The anti-diabetic PPARγ agonist Pioglitazone inhibits cell proliferation and induces metabolic reprogramming in prostate cancer

News Publication Date: 5-May-2025

Web References: http://dx.doi.org/10.1186/s12943-025-02320-y

Image Credits: Medizinische Universität Wien

Keywords: pioglitazone, PPARγ, prostate cancer, metabolic reprogramming, type 2 diabetes, cancer metabolism, drug repurposing, tumor proliferation, inflammation, nuclear receptor, thiazolidinediones

At the core of this research is the recognition that cellular functions are not static; they are intricate and dynamic, influenced by factors such as time, location, and environmental conditions. The cutting-edge chemical tool developed by the research team incorporates light-sensitive mechanisms that permit real-time control over cellular processes. "Cellular processes are complex and constantly change depending on when and where they occur within the cell," says Professor Yaowen Wu, a prominent figure in this study. This newfound capability promises to revolutionize the study of cell biology, enabling researchers to gain insights into how cells maintain their vitality and functionality.

Controlling the intricate interplay of proteins and genes is fundamental to modern biological research. Traditional methodologies, such as the CRISPR-Cas9 genetic editing technique, often operate on extended timelines, introducing the risk of cellular adaptation and potentially obfuscating the results of experiments. The lack of spatial and temporal precision inherent in conventional techniques has posed substantial challenges for scientists wishing to investigate the dynamic nature of cellular functions. Addressing these challenges requires innovative approaches that can operate with precision over short intervals.

This research highlights the emergence of chemo-optogenetic systems as a formidable solution to the hurdles presented by traditional methods. These sophisticated systems blend the properties of chemical compounds, optical technologies, and engineered proteins to deliver precise control over protein activity at defined cellular locations, activated by specific wavelengths of light. The Wu lab is recognized as a leader in advancing the field of chemo-optogenetics, developing tools that enable unprecedented manipulations of light-sensitive proteins to study real-time cellular responses.

Historically, the Wu lab made remarkable strides with systems based on a category of molecular glue that facilitated the interaction between proteins. While these initial systems marked substantial progress, they still bore limitations in terms of usability and stability affected by photo-chemistry, which restricted their broader application in experimental biology. The researchers faced a pressing need to innovate further to overcome these constraints.

In a remarkable development, the Wu lab has recently published two pioneering studies that describe next-generation chemo-optogenetic tools harnessing photoswitchable molecular glues. These advancements significantly enhance the functionalities of prior systems, allowing for more significant versatility and stability. These new molecular glues can be toggled "on" or "off" like a switch through the application of appropriate light wavelengths. This feature enables multiple activation cycles, allowing researchers to alternately stimulate or inhibit protein functions with unprecedented spatial and temporal resolution.

Jun Zhang, a staff scientist at the Department of Chemistry at Umeå University, emphasizes the versatility of the new modular system. This innovative design paradigm enables adaptations to various experimental conditions, expanding the potential applications of these molecular tools in the investigation of protein dynamics and cellular behavior. As a result, scientists now have a reliable means of deciphering the complexities of cellular operations from the subcellular to cellular scale.

The practical implications of these advances are profound. The Wu lab has demonstrated through experimental testing that they can precisely regulate various cellular processes, including but not limited to, the functions and localization of proteins, positioning of organelles within the cell, and modulation of protein levels. This level of control equips biologists with a powerful toolkit to dissect and analyze the multifaceted dimensions of cellular life in real time.

The ability to manipulate proteins and other cellular components with such precision has immense ramifications for many scientific fields, including drug development and disease modeling. By better understanding the interactions of proteins in their natural environments, researchers can illuminate previously inaccessible pathways involved in diseases. More specifically, it could lead to the development of novel therapeutic strategies for a range of conditions, from cancer to neurodegenerative diseases, where protein interactions are known to be critical.

In conclusion, the advancements made by researchers at Umeå University mark an exciting frontier in cell biology research. By leveraging light-activated molecular tools, they have opened new avenues for studying the fundamental processes that govern cellular life. The contributions of this research group not only enhance our understanding of cellular mechanisms but also lay the groundwork for future innovations that could profoundly shape how we approach medical challenges. This research exemplifies the potential of interdisciplinary collaboration, merging chemistry, biology, and technology to forge tools that enhance our ability to explore and manipulate the microscopic world.

As scientists continue to uncover the mysteries of cellular dynamics, the promise of new discoveries hangs tantalizingly in the air. The integration of these advanced technologies heralds a new era in biology, inspiring innovations that could redefine our grasp of life at its most fundamental level.

Subject of Research: Advanced light-controlled tools for protein manipulation in living cells
Article Title: Modular Photoswitchable Molecular Glues for Chemo-optogenetic Control of Protein Function in Living Cells
News Publication Date: 7-Jan-2025
Web References: DOI Link
References: None provided
Image Credits: Shuang Li

Keywords: Biochemistry, Protein functions, Chemo-optogenetics, Cellular processes, Medical advances, Synthetic biology, Protein interactions, Live-cell imaging.